These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 27548565)

  • 41. The epigenome as a target for cancer chemoprevention.
    Kopelovich L; Crowell JA; Fay JR
    J Natl Cancer Inst; 2003 Dec; 95(23):1747-57. PubMed ID: 14652236
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Towards the chemoinformatic-based identification of DNA methyltransferase inhibitors: 2D- and 3D-similarity profile of screening libraries.
    Yoo J; Medina-Franco JL
    Curr Comput Aided Drug Des; 2012 Dec; 8(4):317-29. PubMed ID: 22734709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural characteristics of small-molecule inhibitors targeting
    Gao S; Li X; Zhang M; Zhang N; Wang R; Chang J
    Future Med Chem; 2021 Sep; 13(17):1475-1489. PubMed ID: 34240624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting histone lysine methylation in cancer.
    McGrath J; Trojer P
    Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors.
    Zhang Y; Rong D; Li B; Wang Y
    J Med Chem; 2021 Jun; 64(12):7900-7925. PubMed ID: 33599482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of small molecule inhibitors of human COQ7.
    Tsuganezawa K; Sekimata K; Nakagawa Y; Utata R; Nakamura K; Ogawa N; Koyama H; Shirouzu M; Fukami T; Kita K; Tanaka A
    Bioorg Med Chem; 2020 Jan; 28(1):115182. PubMed ID: 31753803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer.
    Zhang Q; Fan Z; Zhang L; You Q; Wang L
    J Med Chem; 2021 Jul; 64(13):8916-8938. PubMed ID: 34156850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthetic Small Molecule Inhibitors of Hh Signaling As Anti-Cancer Chemotherapeutics.
    Maschinot CA; Pace JR; Hadden MK
    Curr Med Chem; 2015; 22(35):4033-57. PubMed ID: 26310919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A small molecule inhibits protein disulfide isomerase and triggers the chemosensitization of cancer cells.
    Eirich J; Braig S; Schyschka L; Servatius P; Hoffmann J; Hecht S; Fulda S; Zahler S; Antes I; Kazmaier U; Sieber SA; Vollmar AM
    Angew Chem Int Ed Engl; 2014 Nov; 53(47):12960-5. PubMed ID: 25256790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis and biological evaluation studies of novel small molecule ENPP1 inhibitors for cancer immunotherapy.
    Gangar M; Goyal S; Raykar D; Khurana P; Martis AM; Goswami A; Ghoshal I; Patel KV; Nagare Y; Raikar S; Mukherjee A; Cyriac R; Paquin JF; Kulkarni A
    Bioorg Chem; 2022 Feb; 119():105549. PubMed ID: 34929517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.
    Lu C; Jain SU; Hoelper D; Bechet D; Molden RC; Ran L; Murphy D; Venneti S; Hameed M; Pawel BR; Wunder JS; Dickson BC; Lundgren SM; Jani KS; De Jay N; Papillon-Cavanagh S; Andrulis IL; Sawyer SL; Grynspan D; Turcotte RE; Nadaf J; Fahiminiyah S; Muir TW; Majewski J; Thompson CB; Chi P; Garcia BA; Allis CD; Jabado N; Lewis PW
    Science; 2016 May; 352(6287):844-9. PubMed ID: 27174990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and characterization of the first fragment hits for SETDB1 Tudor domain.
    Mader P; Mendoza-Sanchez R; Iqbal A; Dong A; Dobrovetsky E; Corless VB; Liew SK; Houliston SR; De Freitas RF; Smil D; Sena CCD; Kennedy S; Diaz DB; Wu H; Dombrovski L; Allali-Hassani A; Min J; Schapira M; Vedadi M; Brown PJ; Santhakumar V; Yudin AK; Arrowsmith CH
    Bioorg Med Chem; 2019 Sep; 27(17):3866-3878. PubMed ID: 31327677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemistry and Chemical Biology of Therapeutically Important Compounds.
    Disney MD
    Bioorg Med Chem; 2016 Sep; 24(17):3875. PubMed ID: 27460698
    [No Abstract]   [Full Text] [Related]  

  • 54. Rapid synthesis of new DNMT inhibitors derivatives of procainamide.
    Halby L; Champion C; Sénamaud-Beaufort C; Ajjan S; Drujon T; Rajavelu A; Ceccaldi A; Jurkowska R; Lequin O; Nelson WG; Guy A; Jeltsch A; Guianvarc'h D; Ferroud C; Arimondo PB
    Chembiochem; 2012 Jan; 13(1):157-65. PubMed ID: 22170584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective, Small-Molecule Co-Factor Binding Site Inhibition of a Su(var)3-9, Enhancer of Zeste, Trithorax Domain Containing Lysine Methyltransferase.
    Taylor AP; Swewczyk M; Kennedy S; Trush VV; Wu H; Zeng H; Dong A; Ferreira de Freitas R; Tatlock J; Kumpf RA; Wythes M; Casimiro-Garcia A; Denny RA; Parikh MD; Li F; Barsyte-Lovejoy D; Schapira M; Vedadi M; Brown PJ; Arrowsmith CH; Owen DR
    J Med Chem; 2019 Sep; 62(17):7669-7683. PubMed ID: 31415173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting Histone Acetyltransferase MOZ/KAT6A as a New Avenue for Hematological Tumor Therapy.
    Zhou C; Zhu HL; Duan Y
    Curr Top Med Chem; 2020; 20(5):333-335. PubMed ID: 32242512
    [No Abstract]   [Full Text] [Related]  

  • 57. Histone lysine methyltransferases as anti-cancer targets for drug discovery.
    Liu Q; Wang MW
    Acta Pharmacol Sin; 2016 Sep; 37(10):1273-1280. PubMed ID: 27397541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. EDITORIAL: Advances in Developing Versatile Tools for the Discovery of Novel Therapeutics.
    Hu Y
    Curr Top Med Chem; 2017; 17(20):2233-2234. PubMed ID: 28799501
    [No Abstract]   [Full Text] [Related]  

  • 59. IRAK-4 inhibitors. Part 1: a series of amides.
    Buckley GM; Gowers L; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V; Fraser JL
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3211-4. PubMed ID: 18474425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting cancer using KAT inhibitors to mimic lethal knockouts.
    Brown JA; Bourke E; Eriksson LA; Kerin MJ
    Biochem Soc Trans; 2016 Aug; 44(4):979-86. PubMed ID: 27528742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.